Nonaddictive opioid in development at Tulane proves successful in early laboratory testing

The Advocate - A Tulane University professor's 20-year quest to develop a nonaddictive opioid painkiller has cleared another major hurdle in its early phases of laboratory testing.

The drug, known as ZH853, has shown in recent tests to not only accelerate recovery from pain better than morphine, but also to sidestep a key problem with morphine and other prescription painkillers derived from the opium poppy.